Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis

Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis

Abstract Background The purpose of this study was to stratify patients with rheumatoid arthritis (RA) according to the trend of disease activity by trajectory-based clustering and to identify contributing factors for treatment response to biologic and targeted synthetic disease-modifying anti-rheuma...

Full description

Bibliographic Details
Main Authors: Bon San Koo, Seongho Eun, Kichul Shin, Seokchan Hong, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Ji Seon Oh
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Biologics
Trajectory clustering/trajectory modeling
Treatment response
Online Access:https://doi.org/10.1186/s13075-022-02918-3

Similar Items

Similar Items